Genmab
GMAB
$32.01
Share price
2.04%
Change (1 day)
-26.95%
Change (1 year)
Categories
Market capitalization of Genmab (GMAB)
Market cap: A$20.03 Billion
As of April 2025 Genmab has a market cap of A$20.03 Billion. This makes Genmab the world's 1370th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Genmab from 2010 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$20.03 B | -7.18% |
| 2024 | A$21.58 B | -29.3% |
| 2023 | A$30.52 B | -25.69% |
| 2022 | A$41.07 B | 13.73% |
| 2021 | A$36.12 B | 4.09% |
| 2020 | A$34.70 B | 68.52% |
| 2019 | A$20.59 B | 44.66% |
| 2018 | A$14.23 B | 10.24% |
| 2017 | A$12.91 B | -7.24% |
| 2016 | A$13.91 B | 26.74% |
| 2015 | A$10.98 B | 168.21% |
| 2014 | A$4.09 B | 79.85% |
| 2013 | A$2.27 B | 241.07% |
| 2012 | A$0.66 B | 133.05% |
| 2011 | A$0.28 B | -52.01% |
| 2010 | A$0.59 B |
End of Day market cap according to different sources
On Apr 24th, 2025 the market cap of Genmab was reported to be:
